WHO ICTRP trial
Comparative Bioavailability Study of Maxicuma 500 mg Capsule with that of Single…
CTRI/2021/12/038530 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/12/038530 |
|---|---|
| Public title | Comparative Bioavailability Study of Maxicuma 500 mg Capsule with that of Single dose of 95% Curcuminoid 500 mg Capsules in healthy adult human subjects |
| Scientific title | Three Capsules as Single dose Fasting In Vivo Comparative Bioavailability Study of Maxicuma 500 mg Capsule (India Glycols Limited, India) with Three Capsules as Single dose of 95% Curcuminoid 500 mg Capsules (India Glycols Limited, India) in healthy adult, human subjects - Bioequivalence Study |
| Primary sponsor | India Glycols Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | BA/BE |
| Countries | India |
| Registration date | Sep 12, 2021 |
| Target size | 14 |
| Secondary IDs | ARL/CSP/2021/001-00, Version: 00, Date: 28/10/2021 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: